Deal With Eli Lilly Propels Founder Of Korean Biotech Firm Into Billionaire Ranks [Forbes]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Forbes
$2.6 billion licensing and joint research deal with Eli Lilly boosted shares of South Korean biotech company ABL Bio by about 80% over the past week. The stock surge has made Lee Sang-hoon, the company's founder and CEO, South Korea's newest billionaire. Lee, a 62-year-old U.S. citizen, is the largest shareholder of ABL Bio with a 23% stake in his own name worth $1.5 billion, after accounting for pledged shares. (His wife, Yoo Ju-hee, and son, Lee Jin-young, also own tiny stakes in the company.) Based in Seoul's upscale Gangnam neighborhood, ABL Bio has a portfolio of bispecific antibodies, which target two antigens simultaneously to improve treatment outcomes for cancer and neurodegenerative diseases such as Alzheimer's and Parkinson's. The deal with Eli Lilly, which was announced last week, was for licensing and jointly developing new therapies using ABL Bio's Grabody-B, a blood-brain barrier-penetrating bispecific antibody technology. Grabody-B transports medicines across the
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Press Release: Sanofi completes acquisition of VicebioGlobeNewswire
- Sanofi (SAN:CA) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Deutsche Bank Maintains a Buy Rating on Sanofi (SNY) [Yahoo! Finance]Yahoo! Finance
- Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation [Yahoo! Finance]Yahoo! Finance
- AI won't cure cancer, says Sanofi CEO [CNBC]CNBC
SNY
Sec Filings
- 12/3/25 - Form 6-K
- 11/18/25 - Form 6-K
- 11/14/25 - Form SCHEDULE
- SNY's page on the SEC website